Verition Fund Management
KDNY

Verition Fund Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Verition Fund Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,510
Closed -$327K – 2388
2023
Q2 		$327K Buy
+8,510
New +$327K ﹤0.01% 1297